This article is educational and does not provide medical advice or guarantee treatment or results. Product availability, regulatory status, and clinical appropriateness must be confirmed for the individual patient.

Questions to Ask Before Starting a GLP-1 or GIP/GLP-1 Medication

Prescription weight-management medication should be one component of individualized medical care. An online purchase or questionnaire should not guarantee a prescription.

Which exact medication is being offered?

Ask for the active ingredient, brand or compounder, dosage form, strength, and FDA status. FDA-approved branded products and compounded products are not interchangeable. A compounded drug is not FDA-approved and is not a generic version of an approved drug.

Why is it appropriate for me?

A clinician should review health history, current medicines, prior treatment, relevant measurements, contraindications, pregnancy considerations, and the intended follow-up plan.

What results are realistic?

Clinical-trial averages are not promises. Results vary with the medication, dose, duration, population, adherence, health conditions, and accompanying lifestyle program.

What are the risks?

Discuss common gastrointestinal effects, serious warning signs, medication interactions, and when treatment should be paused or stopped. Know whom to contact for side effects and when to seek emergency care.

Who dispenses it?

Before fulfillment, patients should receive the pharmacy’s legal name and contact information, the product’s FDA or compounding status, shipping and storage instructions, total cost, and refill terms.

Nirvanix prefers an FDA-approved medication when available and clinically appropriate. Compounding should occur only when legally permitted and supported by an identified patient-specific clinical need.